Novel erythropoiesis stimulant (Centergene)
长效人红细胞生长刺激素（晟济药业）
Report date: 2022/01/14 13:23:58
Base Information
Drug NameNovel erythropoiesis stimulant (Centergene)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Qiangbang Biological Technology Co LtdSuzhou Shengji Pharmaceutical Co LtdSuzhou Kangju Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesShanghai Qiangbang Biological Technology Co LtdSuzhou Shengji Pharmaceutical Co LtdSuzhou Kangju Biotechnology Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A